‘Why me?’ Helping patients find answers

1 January 2014 0

People with cancer have time to think. Not every patient will think about spiritual matters, but most of us probably do, either alone, or when talking with close family or friends. People with cancer have [more]

People with cancer have time to think. Not every patient will think about spiritual matters, but most of us probably do, either alone, or when talking with close family or friends.... [ more ]

Roger Stupp: What’s so ethical about strangling research?

1 January 2014 0

Patients are losing out because the rules governing research are designed to restrain rather than facilitate. It’s got to change, says Roger Stupp, who is frustrated that 10 years after helping set a new standard [more]

Patients are losing out because the rules governing research are designed to restrain rather than facilitate. It’s got to change, says Roger Stupp, who is frustrated that 10 years after helping set a new standard of care...... [ more ]

Approval rating: how do the EMA and FDA compare?

1 January 2014 0

When new cancer therapies regularly become available more than half a year earlier in the US than in Europe, or get regulatory approval on one side of the Atlantic but not on the other, patients [more]

When new cancer therapies regularly become available more than half a year earlier in the US than in Europe, or get regulatory approval on one side of the Atlantic but not on the other, patients and clinicians want to know why. ... [ more ]

Challenging the sceptics with stories of hope

1 January 2014 0

It was stumbling across a poster for a meeting about cancer in the developing world that turned journalist Joanne Silberner from a sceptic into a believer, and prompted her to do her bit to change [more]

It was stumbling across a poster for a meeting about cancer in the developing world that turned journalist Joanne Silberner from a sceptic into a believer, and prompted her to do her bit to change fatalistic attitudes about...... [ more ]

Imaging in oncology – over a century of advances

1 January 2014 0

Imaging techniques used in staging and evaluation of response to treatment have improved dramatically over the past 120 years. The issue going forward will be learning to combine anatomical and functional imaging modalities to get [more]

Imaging techniques used in staging and evaluation of response to treatment have improved dramatically over the past 120 years. The issue going forward will be learning to combine anatomical and functional imaging modalities...... [ more ]

Complementary or alternative medicine in cancer care – myths and realities

1 January 2014 0

Two practitioners of integrative oncology make the case for using non-traditional therapies alongside mainstream care – and for abandoning the term “complementary and alternative medicine” as unhelpful and misleading – in this comprehensive article, which [more]

wo practitioners of integrative oncology make the case for using non-traditional therapies alongside mainstream care – and for abandoning the term “complementary and alternative medicine” as unhelpful and misleading ... [ more ]

Newsround

1 January 2014 0

Selected reports edited by Janet Fricker Clinical trials lead to cost savings => British Journal of Cancer On average, non-commercial oncology clinical trials are associated with small excess treatment costs compared to the standard of [more]

Selected reports edited by Janet Fricker... [ more ]

My World – Bettina Ryll

1 January 2014 0

Bettina Ryll is a patient advocate and founding member of the Independent Melanoma Community Advisory Board. A qualified doctor, with a PhD in molecular biology, she gained a deeper insight into the reality of cancer, [more]

Bettina Ryll is a patient advocate and founding member of the Independent Melanoma Community Advisory Board. A qualified doctor, with a PhD in molecular biology, she gained a deeper insight into the reality of cancer, and fighting... [ more ]